UB Paderborn / Katalog / Suche / in CDI

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.485-494

2009

Volltextzugriff (PDF)

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-04, Vol.877 (10), p.867-886

2009

Volltextzugriff (PDF)

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-04, Vol.877 (11), p.1057-1069

2009

Volltextzugriff (PDF)

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.97-112

2006

Volltextzugriff (PDF)

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-05, Vol.819 (2), p.259-276

2005

Volltextzugriff (PDF)

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

British journal of cancer, 2008-05, Vol.98 (10), p.1633-1640

2008

Volltextzugriff (PDF)

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.97

2006

Volltextzugriff (PDF)

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Antimicrobial Agents and Chemotherapy, 2009-07, Vol.53 (7), p.3017-3023

2009

Volltextzugriff (PDF)

Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-04, Vol.803 (2), p.285-292

2004

Volltextzugriff (PDF)

Determination of aciclovir and ganciclovir in human plasma by liquid chromatography–spectrofluorimetric detection and stability studies in blood samples

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-06, Vol.852 (1), p.420-429

2007

Volltextzugriff (PDF)

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-10, Vol.810 (1), p.25-34

2004

Volltextzugriff (PDF)

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

Journal of chromatography. B, Biomedical sciences and applications, 2000-03, Vol.740 (1), p.43-58

2000

Volltextzugriff (PDF)

Diet acids and alkalis influence calcium retention in bone

Osteoporosis international, 2001-01, Vol.12 (6), p.493-499

2001

Volltextzugriff (PDF)

OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials

Clinical therapeutics, 2013-08, Vol.35 (8), p.e2-e3

2013

Volltextzugriff (PDF)

Pregnancy outcome following maternal exposure to pregabalin: a reason for concern? a collaborative entis and motherisk study

Clinical therapeutics, 2015-08, Vol.37 (8), p.e1-e1

2015

Volltextzugriff (PDF)

Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC–UV after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-02, Vol.832 (1), p.138-143

2006

Volltextzugriff (PDF)

Pregnancy outcome following maternal exposure to pregabalin may call for concern

Neurology, 2016-06, Vol.86 (24), p.2251

2016

Volltextzugriff (PDF)

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-10, Vol.810 (1), p.25-34

2004

Volltextzugriff (PDF)

Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002-07, Vol.774 (2), p.127-140

2002

Volltextzugriff (PDF)

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

AIDS (London), 2001-01, Vol.15 (1), p.71-75

2001

Volltextzugriff (PDF)

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

AIDS (London), 2001-06, Vol.15 (9), p.1193-1194

2001

Volltextzugriff (PDF)

Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers

Clinical pharmacokinetics, 2002, Vol.41 (2), p.137-152

2002

Volltextzugriff (PDF)

Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro fertilization

Fertility and sterility, 2002-02, Vol.77 (2), p.313-317

2002

Volltextzugriff (PDF)

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

Clinical pharmacology and therapeutics, 2003-01, Vol.73 (1), p.20-30

2003

Volltextzugriff (PDF)

NAT2 and CYP1A2 phenotyping with caffeine: head‐to‐head comparison of AFMU vs. AAMU in the urine metabolite ratios

British journal of clinical pharmacology, 2003-01, Vol.55 (1), p.62-67

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection

Determination of aciclovir and ganciclovir in human plasma by liquid chromatography–spectrofluorimetric detection and stability studies in blood samples

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

Diet acids and alkalis influence calcium retention in bone

OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials

Pregnancy outcome following maternal exposure to pregabalin: a reason for concern? a collaborative entis and motherisk study

Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC–UV after solid-phase extraction

Pregnancy outcome following maternal exposure to pregabalin may call for concern

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers

Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro fertilization

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

NAT2 and CYP1A2 phenotyping with caffeine: head‐to‐head comparison of AFMU vs. AAMU in the urine metabolite ratios

Suchergebnisse filtern